Title: Non‐aminergic Effects of Amphetamine on the NMDA Receptor in Primary Cultured Cortical Cells
Abstract: Annals of the New York Academy of SciencesVolume 801, Issue 1 p. 327-339 Non-aminergic Effects of Amphetamine on the NMDA Receptor in Primary Cultured Cortical Cells HIDEKO YAMAMOTO, Corresponding Author HIDEKO YAMAMOTO Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japane Correspondence: H. Yamamoto, Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2–1–8 Kamikitazawa, Setagaya-ku, Tokyo 156, Japan. Fax: +81–3–3329–8035.Search for more papers by this authorTOSHIFUMI YAMAMOTO, TOSHIFUMI YAMAMOTO Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Laboratory of Molecular Recognition Graduate School of Integrated Science Yokohama City University Yokohama, JapanSearch for more papers by this authorKAORI GOJI, KAORI GOJI Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, JapanSearch for more papers by this authorXIANHONG YANG, XIANHONG YANG Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, JapanSearch for more papers by this authorNOBUTOSHI KAWAI, NOBUTOSHI KAWAI Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Psychiatric Service University of Tsukuba Hospital Tsukuba, JapanSearch for more papers by this authorATSUOMI BABA, ATSUOMI BABA Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Psychiatric Service University of Tsukuba Hospital Tsukuba, JapanSearch for more papers by this authorTAKASHI MOROJI, TAKASHI MOROJI Tokyo Metropolitan Comprehensive Mental Health Center Tama District Tokyo 206, JapanSearch for more papers by this author HIDEKO YAMAMOTO, Corresponding Author HIDEKO YAMAMOTO Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japane Correspondence: H. Yamamoto, Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2–1–8 Kamikitazawa, Setagaya-ku, Tokyo 156, Japan. Fax: +81–3–3329–8035.Search for more papers by this authorTOSHIFUMI YAMAMOTO, TOSHIFUMI YAMAMOTO Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Laboratory of Molecular Recognition Graduate School of Integrated Science Yokohama City University Yokohama, JapanSearch for more papers by this authorKAORI GOJI, KAORI GOJI Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, JapanSearch for more papers by this authorXIANHONG YANG, XIANHONG YANG Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, JapanSearch for more papers by this authorNOBUTOSHI KAWAI, NOBUTOSHI KAWAI Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Psychiatric Service University of Tsukuba Hospital Tsukuba, JapanSearch for more papers by this authorATSUOMI BABA, ATSUOMI BABA Department of Psychopharmacology Tokyo Institute of Psychiatry Tokyo, Japan Psychiatric Service University of Tsukuba Hospital Tsukuba, JapanSearch for more papers by this authorTAKASHI MOROJI, TAKASHI MOROJI Tokyo Metropolitan Comprehensive Mental Health Center Tama District Tokyo 206, JapanSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1749-6632.1996.tb17453.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Moore, K. E. 1978. Amphetamines: biochemical and behavioral actions in animals. In Handbook of Psychopharmacology. L. L. Iversen, S. D. Iversen & S. H. Snyder, Eds. Vol. 11. Stimulants. 41–98. Plenum Press. New York , NY . 2 Angrist, B., G. Sathananthan, S. Wilk & S. Gershon. 1974. J. Psychiatry Res. 11: 13–23. 3 Robinson, T. E., P. A. Jurson, J. A. Bennett & K. M. Bentgen. 1988. Brain Res. 462: 211–222. 4 Kalivas, P. W. & J. Stewart. 1991. Brain Res. Rev. 16: 223–244. 5 Vezina, P. 1993. Brain Res. 605: 332–337. 6 Kamata, K. & G. V. Rebec. 1984. Life Sci. 34: 2419–2427. 7 White, F. J. & R. Y. Wang. 1984. Brain Res. 309: 283–292. 8 Higashi, H., K. Inagawa, S. Nishi & N. Uchimura. 1989. J. Physiol. (London) 408: 587–603. 9 Segal, D. S. & R. Kuczenski. 1992. Brain Res. 571: 330–337. 10 Wolf, M. E., F. J. White & X-T. Hu. 1994. J. Neurosci. 14: 1735–1745. 11 Post, R. M. & S. R. B. Weiss. 1988. Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In Sensitization in the Nervous System. P. W. Kalivas & C. G. Barnes, Eds. 257–291. The Telford Press. Caldwell , NJ . 12 Kirkby, R. D. & L. Kokkinidis. 1987. Exp. Neurol. 97: 270–279. 13 Kirkby, R. D. & L. Kokkinidis. 1990. Brain Res. Bull. 26: 357–364. 14 Karler, R., I. A Chaudhry, L. D. Calder & S. A. Turkanis. 1990. Brain Res. 537: 76–82. 15 Borowski, T. B., R. D. Kirby & L. Kokkinidis. 1993. Brain Res. Bull. 30: 607–610. 16 Karler, R., L. D. Calder, I. A. Chaudhry, S. A. Turkanis. 1989. Life Sci. 45: 599–606. 17 Stewart, J. & J. P. Druhan. 1993. Psychopharmacology 110: 125–132. 18 Wolf, M. E. & M. Jeziorski. 1993. Brain Res. 613: 291–294. 19 Yamamoto, H., T. Yamamoto, N. Sagi, V. Klenerova, K. Goji, N. Kawai, A. Baba, E. Takamori & T. Moroji. 1995. J. Neurosci. 15: 731–736. 20 Kilts, C. D., G. R. Breese & R. B. Mailman. 1981. J. Chromatogr. 225: 347–357. 21 Kato, T., S. Horiuchi, A. Togari & T. Nagatsu. 1981. Experientia 37: 809–811. 22 Hansen, M. B., S. E. Nielson & K. Berg. 1989. J. Immunol. Methods 119: 203–210. 23 Yamamoto, H., T. Yamamoto, N. Sagi, S. Okuyama, N. Kawai, A. Baba & T. Moroji. 1995. Life Sci./Pharmacol. Lett. 56: PL39–PL43. 24 Hori, T., T. Yamamoto, K. Hatta & T. Moroji. 1990. Neurosci. Lett. 119: 9–11. 25 Ujike, H., T. Onoue, K. Akiyama, T. Hamamura & S. Otsuki. 1989. Psychopharmacology 98: 89–92. 26 Chen, L. & L-Y. M. Huang. 1992. Nature 356: 521–523. 27 Urushihara, H., M. Tohda & Y. Nomura. 1992. J. Biol. Chem. 267: 11697–11700. 28 Kitamura, Y., A. Miyazaki, Y. Yamanaka & Y. Nomura. 1993. J. Neurochem. 61: 100–109. 29 Ishii, T., K. Moriyoshi, H. Sughihara, K. Sakurada, H. Kadotani, M. Yokol, C. Akazawa, R. Shigemoto, N. Mizuno, M. Masu & S. Nakanishi. 1993. J. Biol. Chem. 268: 2836–2843. 30 Schulman, H. & P. I. Hanson. 1993. Neurochem. Res. 18: 65–77. 31 Giambalvo, C. T. 1992. Neuropharmacology 31: 1211–1222. 32 Isakov, N., P. McMahon & A. Altman. 1990. J. Biol. Chem. 265: 2091–2097. 33 Markram, H. & M. Segal. 1992. J. Physiol. (London) 457: 491–501. 34 Nestler, E. J., J. J. Erdos, R. Terwilliger, R. S. Duman & J. F. Tallman. 1989. Brain Res. 476: 230–239. 35 McPherson, G. A. 1983. Comput. Programs Biomed. 17: 107–114. 36 Munson, P. J. & D. Rodbard. 1980. Anal. Biochem. 107: 220–239. Citing Literature Volume801, Issue1Cellular and Molecular Mechanisms of Drugs of Abuse: Cocaine, Ibogaine, and Substituted AmphetaminesOctober 1996Pages 327-339 ReferencesRelatedInformation
Publication Year: 1996
Publication Date: 1996-10-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 6
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot